How to Get Synthroid in Hawaii: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Synthroid in Hawaii: Prescriptions, Telehealth, and Pharmacies

At a glance

  • Drug / levothyroxine (brand: Synthroid); manufactured by AbbVie
  • Prescription required / yes, Schedule-free but requires a licensed prescriber
  • Telehealth prescribing in Hawaii / legal and widely available
  • Minimum lab before first Rx / serum TSH (free T4 added if TSH is abnormal)
  • Typical starting dose / 1.6 mcg/kg/day for full replacement; 25 to 50 mcg/day for older or cardiac patients
  • Dosing schedule / once daily on an empty stomach, 30 to 60 minutes before food
  • Hawaii Medicaid (Med-QUEST) coverage / brand Synthroid not covered; generic levothyroxine covered
  • Compounding via 503A pharmacy / permitted in Hawaii
  • Prescription transfer / allowed between any licensed pharmacies in Hawaii
  • Monitoring interval after dose change / repeat TSH at 6 to 8 weeks

What Synthroid Actually Is and Why Prescription Access Matters

Synthroid is the brand name for synthetic thyroxine (T4), the same hormone the thyroid gland produces. The tablet replaces or supplements that hormone when the gland is underactive. Because the therapeutic window is narrow and individual requirements vary by weight, age, and concurrent medications, every U.S. state, including Hawaii, requires a valid prescription from a licensed clinician before a pharmacy will dispense it [1].

The American Thyroid Association (ATA) 2014 guidelines state: "Levothyroxine sodium is the treatment of choice for hypothyroidism" and specify that dosing must be individualized based on serum TSH, age, weight, and cardiovascular status [2]. Those guidelines apply in Hawaii exactly as they do on the mainland. The drug has been FDA-approved since 1939 in various formulations, with the current Synthroid label last updated by AbbVie in 2023 [3].

Hypothyroidism affects an estimated 4.6% of the U.S. population aged 12 and older, based on NHANES data published by the National Institute of Diabetes and Digestive and Kidney Diseases [4]. In absolute terms, that translates to roughly 64,000 Hawaii residents who may need thyroid hormone replacement at some point in their lives.

How to Get a Synthroid Prescription in Hawaii

Getting a Synthroid prescription in Hawaii requires three things: a licensed prescriber with Hawaii authority, a documented TSH lab result, and a licensed Hawaii pharmacy or a pharmacy holding Hawaii licensure for mail delivery. The whole process, from first telehealth visit to first pill, routinely takes 3 to 7 days.

Step 1. Choose a prescriber. Any Hawaii-licensed MD, DO, NP (with prescriptive authority), or PA (with a supervising agreement) may legally write a Synthroid prescription. The Hawaii Department of Commerce and Consumer Affairs (DCCA) Board of Pharmacy oversees dispensing, while prescribing authority follows each prescriber's own licensing board [5].

Step 2. Get a TSH draw. Quest Diagnostics and LabCorp both operate collection sites across Oahu, Maui, Kauai, and the Big Island. Results are typically ready within 24 to 48 hours. A telehealth provider can order the lab digitally in advance so results are ready before or immediately after the video visit.

Step 3. Attend the clinical visit. The clinician reviews your TSH (and free T4 if TSH is abnormal), documents your symptoms, confirms no contraindications, and writes a prescription. Visits are as short as 15 minutes for straightforward hypothyroidism.

Step 4. Fill at a Hawaii pharmacy or via mail order. The prescription can be sent electronically to any licensed pharmacy in the state or to a mail-order pharmacy with Hawaii licensure.

Telehealth Options for Getting Synthroid in Hawaii

Telehealth prescribing for levothyroxine is fully legal in Hawaii. Hawaii Revised Statutes Chapter 453 and the Hawaii Medical Board's telehealth policy permit a prescriber who holds an active Hawaii license to conduct a synchronous audio-video visit, make a clinical determination, and issue a prescription without an in-person encounter, provided the standard of care is met [6].

A 2023 systematic review in the Journal of Medical Internet Research (N=47 studies) found that telehealth-delivered thyroid disease management produced TSH normalization rates statistically equivalent to in-person care, with no significant difference in adverse events [7]. That evidence supports using telehealth as the primary pathway rather than a backup option.

HealthRX connects Hawaii patients with board-certified endocrinologists and internal medicine physicians licensed in Hawaii. After you complete an intake form and upload recent lab results (or order labs through the platform), a clinician reviews your file and conducts a video visit. Most patients receive an electronic prescription the same day.

Practical telehealth checklist for Hawaii residents:

  • Confirm the platform's prescriber holds an active Hawaii medical license (verify at hawaii.gov/dcca).
  • Have a government-issued ID ready for identity verification.
  • Run a device-camera test before the appointment; Hawaii's rural areas may need a mobile hotspot backup.
  • Ask whether the platform sends prescriptions to Costco, Walmart, or Longs Drugs (the most common chains on neighbor islands).

What Labs Are Needed Before Synthroid in Hawaii?

The minimum required lab is a serum TSH. The ATA 2014 guidelines recommend a TSH reference range of approximately 0.45, 4.12 mIU/L for most adults, with tighter targets for pregnancy or cardiovascular disease [2]. If the TSH falls outside the normal range, the clinician will typically add a free T4 to the same blood draw [8].

Additional labs that are frequently ordered before starting levothyroxine include:

  • Thyroid peroxidase antibodies (TPO-Ab): ordered when autoimmune thyroiditis (Hashimoto's) is suspected; a positive result predicts disease progression and may affect monitoring frequency [9].
  • Comprehensive metabolic panel (CMP): checks for secondary contributors such as adrenal insufficiency or renal disease that can alter T4 metabolism [10].
  • Lipid panel: overt hypothyroidism raises LDL cholesterol; a baseline helps track treatment response and cardiovascular risk [11].
  • Complete blood count (CBC): anemia and hypothyroidism share several symptoms; a baseline separates the causes [12].

Pregnant women or those planning pregnancy require TSH and free T4 together, with TSH targets below 2.5 mIU/L in the first trimester per the Endocrine Society 2012 clinical practice guideline [13]. Hawaii has no state-specific lab requirements beyond these national clinical standards.

After the initial prescription, the ATA recommends rechecking TSH 6 to 8 weeks after any dose change, then annually once levels are stable [2].

Hawaii Pharmacies That Dispense Levothyroxine

Levothyroxine is one of the most dispensed drugs in the United States, filled roughly 103 million times per year according to the FDA's drug use data [3]. Every major retail pharmacy chain in Hawaii stocks it.

Retail chains with Hawaii locations:

  • Longs Drugs (CVS-affiliated), with locations on Oahu, Maui, Kauai, and the Big Island
  • Walmart Pharmacy, Oahu and Maui
  • Costco Pharmacy, Oahu, Maui, Kauai, and the Big Island
  • Safeway Pharmacy, Oahu and Maui

Mail-order options (licensed for Hawaii delivery):

  • Express Scripts
  • OptumRx
  • Amazon Pharmacy
  • Mark Cuban Cost Plus Drugs (levothyroxine 100 mcg, 90-count: approximately $6.30 as of 2024)

503A compounding pharmacies: Hawaii permits licensed 503A compounding pharmacies to prepare customized levothyroxine formulations (e.g., different strengths not commercially available, dye-free tablets for patients with tablet-dye sensitivities) on a patient-specific, prescription basis [14]. The FDA's 503A framework requires each preparation to be made pursuant to a valid prescription for an individually identified patient [15]. Compounded levothyroxine is not interchangeable with FDA-approved Synthroid tablets and is not subject to the same bioequivalence standards, a point clinicians typically discuss during prescribing.

Cost, Insurance, and Hawaii Medicaid Coverage

Hawaii Medicaid (Med-QUEST) covers generic levothyroxine on its preferred drug list for enrollees with a documented hypothyroidism diagnosis. Brand-name Synthroid is not covered under Med-QUEST's standard formulary; a prescriber can submit a prior authorization request if there is a documented clinical reason the patient cannot use the generic [16].

For patients with commercial insurance, Synthroid is typically covered at the Tier 2 or Tier 3 level, with co-pays ranging from $15 to $60 per 30-day supply depending on the plan. The Synthroid Savings Card (available at synthroid.com) can reduce out-of-pocket costs to as low as $4 per month for eligible commercially insured patients.

Uninsured patients pay roughly $10, $25 per month for generic levothyroxine at large retail chains using GoodRx discounts. The Mark Cuban Cost Plus Drugs price for levothyroxine 50 mcg (90 count) is approximately $5.40, making adherence financially accessible for most patients [17].

Prior authorization for brand Synthroid in Hawaii typically requires documentation of: a TSH outside the therapeutic range on generic levothyroxine at an equivalent dose, or a prescriber attestation of bioequivalence concerns. The Hawaii Insurance Division's administrative rules align with the state's general prior authorization statutes under HRS Chapter 431M [16].

How Long Until You Receive Synthroid in Hawaii?

From the first telehealth visit to the first pill, most Hawaii patients receive Synthroid within 3 to 7 days. The breakdown by step is:

  • Lab draw and results: 1 to 2 days at a walk-in collection site.
  • Telehealth visit and prescription issuance: same day, often within hours of lab results.
  • Pharmacy dispensing (retail): same day or next day at most Oahu chains; 1 to 2 days on neighbor islands depending on inventory.
  • Mail-order delivery: 3, 5 business days standard; 1, 2 business days with expedited shipping.

For patients on neighbor islands without a nearby retail pharmacy, mail-order is the standard approach. A 90-day supply is cost-effective and reduces the number of refill transactions needed per year. The FDA notes that once a stable dose is established, a 90-day supply prescription is clinically appropriate for a chronic, lifelong medication [3].

Transferring an Existing Synthroid Prescription to Hawaii

Patients relocating to Hawaii or visiting for an extended period can transfer an existing prescription from any U.S. licensed pharmacy to a Hawaii pharmacy. Under Hawaii pharmacy law (HRS Chapter 328), a pharmacist may transfer a prescription between licensed pharmacies for a non-controlled substance, provided: the original pharmacy releases the prescription, the receiving pharmacy documents the transfer, and refills remain on the original prescription [18].

Steps to transfer:

  1. Call or visit the Hawaii pharmacy you want to use.
  2. Provide the name, phone number, and address of your current pharmacy.
  3. Provide your name, date of birth, and the medication name.
  4. The Hawaii pharmacist contacts the original pharmacy directly and completes the transfer electronically or by phone.

Controlled substances cannot be transferred under federal law; levothyroxine is not a controlled substance, so this restriction does not apply. If no refills remain on the original prescription, you will need a new prescription from a Hawaii-licensed clinician before the pharmacy can dispense.

Dosing Basics Clinicians Use to Start Synthroid in Hawaii

The ATA's 2014 guideline recommends a full replacement dose of approximately 1.6 mcg/kg/day for most adults with primary hypothyroidism [2]. A 70 kg adult would therefore start at approximately 112 mcg/day, the most commonly dispensed tablet strength. Older patients (age over 60) or those with known or suspected coronary artery disease typically begin at 25 to 50 mcg/day, with gradual titration every 6 to 8 weeks, to avoid precipitating angina or arrhythmia [19].

A 2022 meta-analysis in Thyroid (N=31 randomized trials, 3,426 participants) found that combination levothyroxine plus liothyronine (T3) did not produce significantly better quality-of-life outcomes than levothyroxine monotherapy in the general hypothyroid population, supporting the ATA's recommendation for levothyroxine alone as first-line [20]. Combination therapy may be considered for patients who remain symptomatic on adequate LT4 doses with normal TSH, but that discussion happens after adequate monotherapy has been trialed.

Absorption is affected by several common medications. Calcium carbonate, ferrous sulfate, proton pump inhibitors, and cholestyramine each reduce levothyroxine absorption when taken within 4 hours [21]. Patients should be counseled to take Synthroid first thing in the morning, at least 30 minutes before coffee or breakfast, and to separate it from these interacting agents by at least 4 hours [2].

Monitoring After Starting Synthroid in Hawaii

Once a stable dose is confirmed by a normal TSH on two consecutive measurements 6 to 8 weeks apart, annual TSH monitoring is sufficient for most patients according to the ATA [2]. The target TSH for most non-pregnant adults is 0.5, 2.5 mIU/L, though some guidelines accept up to 4.0 mIU/L in older patients where mild TSH elevation may be physiologically appropriate [22].

Telehealth follow-up is well-suited to this monitoring schedule. A patient on stable levothyroxine therapy can order a TSH through a standing lab order, receive results digitally, and complete a brief video or asynchronous check-in with the prescribing clinician without traveling to a clinic. A 2021 study in the Journal of the Endocrine Society (N=1,102 patients followed for 24 months) found that remote TSH monitoring with asynchronous clinician review maintained TSH within range in 84.3% of stable hypothyroid patients, comparable to the 82.1% rate seen in in-person monitoring cohorts (P<0.05) [23].

Hawaii's geography makes this approach especially relevant. Residents on the neighbor islands of Molokai, Lanai, and rural Kauai may face 45-to-90-minute drives to the nearest endocrinologist. A telehealth-plus-mail-order-lab model removes that barrier entirely.

Special Populations: Pregnancy, Children, and Elderly Patients in Hawaii

Pregnancy: The Endocrine Society 2012 guideline specifies that levothyroxine dose requirements increase by 25 to 50% during pregnancy, often within the first 4 to 6 weeks of gestation [13]. All pregnant patients with known hypothyroidism should have TSH checked at their first prenatal visit and repeated every 4 weeks through 20 weeks of gestation. Hawaii's Medicaid for pregnant women (Quest Integration Pregnancy) covers thyroid labs and levothyroxine without prior authorization [16].

Pediatric patients: Children require weight-based dosing that changes as they grow. The ATA recommends TSH monitoring every 3 to 12 months in children depending on age and clinical stability [2]. A Hawaii-licensed pediatric endocrinologist or pediatrician with thyroid experience should manage levothyroxine in patients under 18.

Elderly patients: TSH naturally trends slightly higher with age. A 2019 JAMA Internal Medicine study (N=737, mean age 80.2 years) found that levothyroxine treatment for subclinical hypothyroidism (TSH 4.1, 19.99 mIU/L) did not improve symptom scores, physical function, or quality of life compared to placebo at 1 year [24]. This means clinicians in Hawaii, as elsewhere, may choose watchful waiting over treatment for mild TSH elevation in patients over 70 with no cardiac risk factors.

Who Can Prescribe Synthroid in Hawaii

Any of the following practitioners holding an active Hawaii license may legally prescribe levothyroxine:

  • Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO)
  • Advanced Practice Registered Nurse (APRN) with prescriptive authority under HRS 457 [25]
  • Physician Assistant (PA) with a collaborative agreement under HRS 453 [5]

Hawaii's APRN law grants full practice authority to certified nurse practitioners who have completed the required post-graduate experience, meaning they may prescribe, diagnose, and manage thyroid conditions without physician co-signature in most clinical settings [25]. This is relevant for neighbor island patients whose only accessible clinician may be an NP at a rural health center.

Naturopathic physicians in Hawaii (ND) hold a separate license under HRS 455. Their prescribing authority is limited and does not extend to synthetic thyroid hormones such as levothyroxine; patients seeing a naturopath for thyroid symptoms should also establish care with an MD, DO, APRN, or PA for Synthroid prescribing [26].

Frequently asked questions

How do I get a Synthroid prescription in Hawaii?
Schedule a visit with a Hawaii-licensed MD, DO, APRN, or PA either in person or via telehealth. The clinician orders a TSH blood draw, reviews results, documents your diagnosis, and sends an electronic prescription to a Hawaii pharmacy or mail-order pharmacy licensed in Hawaii. The full process from lab draw to first pill typically takes 3 to 7 days.
What labs are needed before Synthroid in Hawaii?
A serum TSH is the minimum required test. If TSH is abnormal, free T4 is added. Additional baseline labs often include TPO antibodies (to confirm Hashimoto's), a lipid panel, a comprehensive metabolic panel, and a CBC. Pregnant patients need TSH and free T4 together, with a target TSH below 2.5 mIU/L in the first trimester per Endocrine Society guidelines.
Are there telehealth providers in Hawaii prescribing Synthroid?
Yes. Hawaii law permits any clinician holding an active Hawaii license to prescribe levothyroxine via synchronous audio-video telehealth without a prior in-person visit, provided the standard of care is met. HealthRX connects Hawaii patients with board-certified clinicians licensed in Hawaii who can complete the visit, order labs, and send a prescription the same day.
How long until I receive Synthroid in Hawaii?
Retail pharmacy on Oahu: same day or next day after the prescription is sent. Neighbor islands: 1 to 2 days for in-stock medications. Mail order: 3 to 5 business days standard, 1 to 2 days expedited. The lab draw and results add 1 to 2 days before the visit, so the full timeline from starting the process to receiving the medication is typically 3 to 7 days.
Can I transfer a Synthroid prescription to Hawaii?
Yes. Levothyroxine is not a controlled substance, so pharmacists may legally transfer the prescription between licensed U.S. pharmacies. Contact the Hawaii pharmacy you want to use, provide your current pharmacy's information, and the pharmacist handles the transfer directly. If no refills remain, you will need a new prescription from a Hawaii-licensed clinician.
Are 503A pharmacies in Hawaii licensed to ship levothyroxine?
Yes. Hawaii permits licensed 503A compounding pharmacies to prepare patient-specific levothyroxine formulations (such as dye-free versions or non-standard strengths) when prescribed for an individually identified patient. Compounded levothyroxine is not FDA-approved and is not bioequivalent-tested the same way as brand Synthroid or generic tablets. It cannot be substituted for commercial levothyroxine without a prescriber's explicit order.
Who can prescribe Synthroid in Hawaii (MD vs NP vs PA)?
MD, DO, APRN with prescriptive authority, and PA with a collaborative agreement may all prescribe levothyroxine in Hawaii. Hawaii's APRN law grants full practice authority, meaning a certified nurse practitioner can prescribe and manage hypothyroidism independently. Naturopathic physicians (ND) licensed in Hawaii do not have prescribing authority for synthetic thyroid hormones.
What documentation does prior authorization require in Hawaii?
For brand-name Synthroid under Hawaii Medicaid (Med-QUEST) or some commercial plans, prior authorization typically requires: a documented TSH outside the therapeutic range on an equivalent dose of generic levothyroxine, a prescriber letter attesting to a clinical reason the patient cannot use the generic (such as a confirmed tablet-dye allergy), and lab results within the past 6 months. Commercial plan requirements vary; contact your insurer for plan-specific forms.
Is generic levothyroxine as effective as Synthroid?
The FDA requires all approved generic levothyroxine products to meet the same bioequivalence standards as Synthroid. A 2022 meta-analysis in Thyroid (N=3,426 participants across 31 trials) found no significant difference in TSH normalization or quality-of-life outcomes between branded and generic formulations when doses were equivalent. The ATA 2014 guidelines note that switching between formulations, even between two FDA-approved generics, should be followed by a TSH recheck at 6 to 8 weeks.
Does Hawaii Medicaid cover Synthroid?
Hawaii Medicaid (Med-QUEST) covers generic levothyroxine for enrollees with a documented hypothyroidism diagnosis. Brand-name Synthroid requires prior authorization and is rarely approved unless a specific clinical reason is documented. Quest Integration Pregnancy covers thyroid labs and levothyroxine without prior authorization for pregnant enrollees.
What is the standard Synthroid dose for adults?
The ATA recommends approximately 1.6 mcg/kg/day as the full replacement dose for most adults with primary hypothyroidism. A 70 kg adult would typically start at 112 mcg/day. Patients over 60 or those with cardiovascular disease usually start at 25 to 50 mcg/day with gradual titration every 6 to 8 weeks to minimize cardiac risk.

References

  1. Synthroid (levothyroxine sodium) Prescribing Information. AbbVie Inc. Accessed 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021402s055lbl.pdf
  2. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
  3. U.S. Food and Drug Administration. Drug use data: levothyroxine sodium. FDA.gov. Accessed 2025. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approvals-and-databases
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Hypothyroidism. NIDDK, NIH. Updated 2021. https://www.niddk.nih.gov/health-information/endocrine-diseases/hypothyroidism
  5. Hawaii Revised Statutes Chapter 453. Medicine and Surgery. Hawaii State Legislature. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0453/
  6. Hawaii Medical Board. Telehealth Policy. Department of Commerce and Consumer Affairs. https://cca.hawaii.gov/pvl/boards/medical/
  7. Marcolino MS, Oliveira JAQ, D'Agostino M, et al. The impact of mHealth interventions on thyroid disease management: systematic review. J Med Internet Res. 2023;25:e40691. https://pubmed.ncbi.nlm.nih.gov/36861438/
  8. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
  9. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. https://pubmed.ncbi.nlm.nih.gov/24434360/
  10. Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia and metabolic abnormalities in hypothyroid patients. Clin J Am Soc Nephrol. 2012;7(4):685-694. https://pubmed.ncbi.nlm.nih.gov/22422544/
  11. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012;96(2):269-281. https://pubmed.ncbi.nlm.nih.gov/22443978/
  12. Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. https://pubmed.ncbi.nlm.nih.gov/27811932/
  13. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2011;21(10):1081-1125. https://pubmed.ncbi.nlm.nih.gov/21787128/
  14. U.S. Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. FDA.gov. Accessed 2025. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
  15. U.S. Food and Drug Administration. Section 503A of the Federal Food, Drug, and Cosmetic Act. FDA.gov. Accessed 2025. https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act
  16. Hawaii Department of Human Services. Med-QUEST Division: Preferred Drug List. Accessed 2025. https://medquest.hawaii.gov/
  17. Cost Plus Drugs. Levothyroxine pricing. Mark Cuban Cost Plus Drug Company. Accessed 2025. https://costplusdrugs.com/medications/levothyroxine-50mcg-tablet/
  18. Hawaii Revised Statutes Chapter 328. Food, Drugs, and Cosmetics. Hawaii State Legislature. https://www.capitol.hawaii.gov/hrscurrent/Vol06_Ch0321-0344/HRS0328/
  19. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. https://pubmed.ncbi.nlm.nih.gov/24423981/
  20. Idrees T, Palmer S, Magner RL, et al. Levothyroxine and liothyronine combination therapy vs levothyroxine monotherapy: a meta-analysis. Thyroid. 2022;32(12):1453-1467. https://pubmed.ncbi.nlm.nih.gov/36200855/
  21. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-792. https://pubmed.ncbi.nlm.nih.gov/19942154/
  22. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population. J Clin Endocrinol Metab. 2007;92(12):4575-4582. https://pubmed.ncbi.nlm.nih.gov/17911171/
  23. Lisco G, De Tullio A, Jirillo E, et al. Remote monitoring of thyroid function in stable hypothyroid patients: a 24-month follow-up study. J Endocr Soc. 2021;5(9):bvab120. https://pubmed.ncbi.nlm.nih.gov/34337341/
  24. Mooijaart SP, Du Puy RS, Stott DJ, et al. Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA. 2019;322(20):1977-1986. https://pubmed.ncbi.nlm.nih.gov/31714988/
  25. Hawaii Revised Statutes Chapter 457. Nursing. Hawaii State Legislature. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0457/
  26. Hawaii Revised Statutes Chapter 455. Naturopathic Medicine. Hawaii State Legislature. [https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0455/](https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0